Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain

Table 3 Differences according to year of diagnosis of infection, n (%)

Demographic parameters		Total	Diagnosis before 2000	Diagnosis after 2000	P value
Country of birth by region					< 0.00
Spain		47 (67.1)	37 (92.5)	10 (33.3)
Eastern Europe		17 (24.3)	3(7.5)	14 (46.7)
Other		6 (8.6)	0 (0)	6 (20)
Diabetes mellitus	Diabetic	6 (8.6)	1 (2.3)	5 (16.7)	0.038
Alcohol consumption	Alcohol consumption	24 (34.3)	12 (30)	12 (41.4)	0.327
Weight					0.038
Underweight		2 (2.9)	1 (2.7)	1 (3.8)
Normal weight		26 (37.1)	12 (32.4)	14 (53.8)
Overweight		23 (32.9)	14 (37.8)	9 (34.6)
Obese		12 (17.1)	10 (27)	2 (7.7)
Serologic parameters
HBe antigen	HBeAg +	8 (11.4)	8 (11.4)	0 (0)	0.008
HIV	Anti-HIV-IgG +	7 (10)	7 (10)	0 (0)	0.024
HCV	Anti-HCV-IgG+	8 (11.4)	8 (11.4)	0 (0)	0.009
Events
Progression to cirrhosis		54 (77.1)	33 (82.5)	21 (72.4)	0.316
Liver decompensation		39 (72.2)	24 (77.4)	15 (75)	0.842
Liver transplant		32 (45.7)	22 (55)	10 (33.3)	0.74
Death		4 (5.7)	2 (5)	2 (6.7)	0.766

HBe: Hepatitis B e; HCV: Hepatitis C virus; HIV: Human immunodeficiency virus.